Skin Diseases  >>  omiganan (CLS001)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
omiganan (CLS001) / Maruho
NCT02028286: A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

Completed
1
25
US
CLS001
Maruho Co., Ltd.
Papulopustular Rosacea
03/14
 

Download Options